Eva Solis

Eva Solis is an accomplished business leader specializing in the rare disease sector, currently serving as the West Zone Business Director for Rare Disease at Travere Therapeutics since April 2022. Prior to this role, Eva held positions at Reata Pharmaceuticals, Inc. as Regional Business Director for West in Rare Disease Nephrology, and at NS Pharma, Inc. as Regional Business Director for West in Ultra Rare Disease Neurology. Eva's career also includes significant roles at Portola Pharmaceuticals and Sanofi, where expertise spanned cardiology, pulmonology, neurology, and various therapeutic areas, contributing to comprehensive strategies in sales and operations for multiple high-stakes projects.